ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TXG 10x Genomics Inc

20.20
0.48 (2.43%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,245,595
Bid Price 19.95
Ask Price 36.61
News -
Day High 20.295

Low
19.34

52 Week Range

High
63.57

Day Low 19.34
Share Name Share Symbol Market Stock Type
10x Genomics Inc TXG NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.48 2.43% 20.20 23:00:05
Open Price Low Price High Price Close Price Previous Close
19.61 19.34 20.295 20.25 19.72
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
20,822 1,245,595 US$ 19.78 US$ 24,640,222 - 19.34 - 63.57
Last Trade Type Quantity Price Currency
18:22:46 5 US$ 20.23 USD

10x Genomics (TXG) Options Flow Summary

Overall Flow

Bullish

Net Premium

29k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

10x Genomics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.41B 119.17M - 618.73M -255.1M -2.14 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

10x Genomics News

Date Time Source News Article
6/13/202415:08Edgar (US Regulatory)Form 8-K - Current report
6/06/202415:13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
5/31/202415:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202415:05PR Newswire (US)10x Genomics Launches 5,000-Plex Gene Panel for Xenium
5/23/202418:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/23/202418:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/23/202418:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/22/202415:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/22/202415:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/22/202415:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/02/202415:05PR Newswire (US)10x Genomics to Present at the BofA Securities 2024..
4/30/202415:05PR Newswire (US)10x Genomics Reports First Quarter 2024 Financial Results
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TXG Message Board. Create One! See More Posts on TXG Message Board See More Message Board Posts

Historical TXG Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week22.0822.740819.3421.201,133,519-1.88-8.51%
1 Month25.6525.6519.3422.611,310,267-5.45-21.25%
3 Months38.0938.4919.3428.041,605,243-17.89-46.97%
6 Months53.5757.9019.3436.971,477,552-33.37-62.29%
1 Year58.6563.5719.3441.251,212,846-38.45-65.56%
3 Years192.99208.9919.3460.121,131,415-172.79-89.53%
5 Years54.00208.9919.3475.52954,420-33.80-62.59%

10x Genomics Description

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Your Recent History

Delayed Upgrade Clock